Leung J, Chiu H, Taneja R
Br J Cancer. 2025; .
PMID: 40055485
DOI: 10.1038/s41416-025-02961-2.
Hua X, Yu L, Zhu H, Zhu Y, Fan G, Zhou G
Front Oncol. 2025; 15:1481322.
PMID: 39931083
PMC: 11807992.
DOI: 10.3389/fonc.2025.1481322.
Sanati M, Ghafouri-Fard S
Cell Commun Signal. 2024; 22(1):572.
PMID: 39614315
PMC: 11607985.
DOI: 10.1186/s12964-024-01952-9.
Elemam N, Mekky R, Rashid G, Braoudaki M, Youness R
Expert Rev Mol Med. 2024; 26:e1.
PMID: 38186186
PMC: 10941350.
DOI: 10.1017/erm.2023.26.
Lu S, Liang Y, Li L, Liao S, Zou Y, Yang C
BMC Genomics. 2023; 24(1):796.
PMID: 38129810
PMC: 10734204.
DOI: 10.1186/s12864-023-09899-w.
The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review.
Tippett V, Tattersall L, Ab Latif N, Shah K, Lawson M, Gartland A
Oncogene. 2022; 42(4):259-277.
PMID: 36434179
PMC: 9859755.
DOI: 10.1038/s41388-022-02529-x.
Noncoding RNA PVT1 in osteosarcoma: The roles of lncRNA PVT1 and circPVT1.
Wu T, Ji Z, Lin H, Wei B, Xie G, Ji G
Cell Death Discov. 2022; 8(1):456.
PMID: 36379920
PMC: 9666356.
DOI: 10.1038/s41420-022-01192-1.
Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review.
Chen H, Zhang T, Zhang F, Zhang T
Elife. 2022; 11.
PMID: 36326232
PMC: 9691005.
DOI: 10.7554/eLife.79655.
An overview of resistance to chemotherapy in osteosarcoma and future perspectives.
Garcia-Ortega D, Cabrera-Nieto S, Caro-Sanchez H, Cruz-Ramos M
Cancer Drug Resist. 2022; 5(3):762-793.
PMID: 36176756
PMC: 9511812.
DOI: 10.20517/cdr.2022.18.
Prognostic and clinicopathologic significance of circZFR in multiple human cancers.
Liu Z, Zhang W, Tu C, Li W, Qi L, Zhang Z
World J Surg Oncol. 2022; 20(1):268.
PMID: 36008845
PMC: 9413939.
DOI: 10.1186/s12957-022-02733-9.
Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis.
Shao G, Fan X, Zhang P, Liu X, Huang L, Ji S
Cell Biol Toxicol. 2022; 39(5):2183-2205.
PMID: 35870038
DOI: 10.1007/s10565-022-09704-6.
Identification of Key Genes and Pathways Associated with in Bone-Related Disease Based on Bioinformatics.
Zhou Y, Zhang C, Zhou Z, Zhang C, Wang J
Int J Mol Sci. 2022; 23(9).
PMID: 35563641
PMC: 9104149.
DOI: 10.3390/ijms23095250.
Circular RNA_ANKIB1 accelerates chemo-resistance of osteosarcoma via binding microRNA-26b-5p and modulating enhancer of zeste homolog 2.
Tang J, Duan G, Wang Y, Wang B, Li W, Zhu Z
Bioengineered. 2022; 13(3):7351-7366.
PMID: 35264070
PMC: 8974058.
DOI: 10.1080/21655979.2022.2037869.
Circular RNA expression pattern in cisplatin-resistant osteosarcoma cells.
Han J, Ye Z, Kong Q, Wu F, Wang G, Wang K
Transl Cancer Res. 2022; 9(1):262-270.
PMID: 35117180
PMC: 8798253.
DOI: 10.21037/tcr.2019.12.80.
Screening differential circular RNA expression profiles reveals the regulatory role of circMARS in anti-tuberculosis drug-induced liver injury.
Li B, Ren Q, Li Y, Tian S, Chong Y, Sun S
J Cell Mol Med. 2022; 26(4):1050-1059.
PMID: 35032098
PMC: 8831982.
DOI: 10.1111/jcmm.17157.
Dissecting the Role of Circular RNAs in Sarcomas with Emphasis on Osteosarcomas.
Lakiotaki E, Kanakoglou D, Pampalou A, Karatrasoglou E, Piperi C, Korkolopoulou P
Biomedicines. 2021; 9(11).
PMID: 34829872
PMC: 8615931.
DOI: 10.3390/biomedicines9111642.
Identification of Conserved Pappalysin 1-Derived Circular RNA-Mediated Competing Endogenous RNA in Osteosarcoma.
Ming G, Gao B, Chen P
Evol Bioinform Online. 2021; 17:11769343211041379.
PMID: 34707339
PMC: 8544760.
DOI: 10.1177/11769343211041379.
Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p.
Ma X, Zhan T, Hu J, Zhang C, Zhu K
Cell Death Discov. 2021; 7(1):309.
PMID: 34689155
PMC: 8542045.
DOI: 10.1038/s41420-021-00694-8.
Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis.
Zhong J, Zhang G, Yao W
J Orthop Surg Res. 2021; 16(1):578.
PMID: 34620208
PMC: 8495992.
DOI: 10.1186/s13018-021-02568-2.
Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p/FBN1 axis.
Bai Y, Li Y, Bai J, Zhang Y
J Orthop Surg Res. 2021; 16(1):510.
PMID: 34407841
PMC: 8371803.
DOI: 10.1186/s13018-021-02631-y.